SCHEMBL7064869

SCHEMBL7064869

CCOC(=O)c1ncn(C[C@H]2CC[C@H]3CN[C@H](C(=O)OCC)C[C@H]3C2)c1C(=O)OCC

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GRIK1 P39086 8/20 0.37
GRIK2 Q13002 1/20 0.35
GRIK3 Q13003 1/20 0.35
GRIK5 Q16478 1/20 0.35
GRIA1 P42261 2/20 0.34
GRIA2 P42262 2/20 0.34
GRIA3 P42263 2/20 0.34
GRIA4 P48058 2/20 0.34
GRIN2D O15399 1/20 0.34
GRIN3B O60391 1/20 0.34
GRIN1 Q05586 1/20 0.34
GRIN2A Q12879 1/20 0.34
GRIN2B Q13224 1/20 0.34
GRIN2C Q14957 1/20 0.34
GRIN3A Q8TCU5 1/20 0.34
KDM4E B2RXH2 1/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7068326 0.99 GRIK1 (0.38) GRIK1GRIK2GRIK3GRIK5GRIA1
SCHEMBL7070983 0.92 GRIK1 (0.36) GRIK1GRIK2GRIK3GRIK5GRIA1
Hydrochloric Acid SCHEMBL7069651 0.92 GRIK1 (0.46) GRIK1GRIK2GRIK3GRIK5GRIA1
Hydrochloric Acid SCHEMBL7066442 0.91 GRIK1 (0.37) GRIK1GRIK2GRIK3GRIK5GRIA1
Hydrochloric Acid SCHEMBL7066452 0.81 CYP1A2 (0.38) GRIK1GRIK2GRIK3GRIK5GRIA1
SCHEMBL7065145 0.80 USP30 (0.36) GRIK1GRIK2GRIK3GRIK5GRIA1
Hydrochloric Acid SCHEMBL7065324 0.79 GRIK1 (0.36) GRIK1GRIK2GRIK3GRIK5GRIA1
SCHEMBL7066267 0.78 DHFR (0.33)
SCHEMBL7064873 0.77 TP53 (0.30)
SCHEMBL7068736 0.76 USP30 (0.35) GRIK1GRIK2GRIK3GRIK5GRIA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6579886-B2 Ionotropic glutamate receptors; 6-((4-carboxylic acid-1H-imidazol-1-yl)methyl)-1,2,3,4,4a,5,6,7,8,8a-decahydroisoquinoline-3 -carboxylic acid ELI LILLY AND COMPANY 2003-06-17 US disclosed
US-20030055081-A1 Selective iglur5 receptor antagonists ELI LILLY AND COMPANY 2003-03-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030055081-A1 Selective iglur5 receptor antagonists GRM5, GRIK5, GPR35 GRIK1 19/4885GRIK2 12/4885GRIK3 26/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.